Dr. Lal Path Labs Ltd.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomi… Read more
Dr. Lal Path Labs Ltd. (LALPATHLAB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.134x
Based on the latest financial reports, Dr. Lal Path Labs Ltd. (LALPATHLAB) has a cash flow conversion efficiency ratio of 0.134x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹3.24 Billion) by net assets (₹24.22 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Dr. Lal Path Labs Ltd. - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Dr. Lal Path Labs Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Dr. Lal Path Labs Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dr. Lal Path Labs Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PTT OIL & RETAIL BUSINE-NVDR
BK:OR-R
|
0.000x |
|
Innovative Medical Management Co Ltd
SHE:002173
|
-0.007x |
|
Thai Union Group Public Company Limited
PINK:THFRF
|
0.056x |
|
Beijing Watertek Information Technology Co Ltd
SHE:300324
|
0.004x |
|
MFE MEDIAFOREUROPE NV
LSE:0NE1
|
0.117x |
|
BEIJER ALMA AB B SK 2083
F:6O4
|
N/A |
|
AnaptysBio Inc
NASDAQ:ANAB
|
2.634x |
|
Zhongshan Public Utilities Group Co Ltd
SHE:000685
|
0.020x |
Annual Cash Flow Conversion Efficiency for Dr. Lal Path Labs Ltd. (2011–2025)
The table below shows the annual cash flow conversion efficiency of Dr. Lal Path Labs Ltd. from 2011 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹22.07 Billion | ₹5.69 Billion | 0.258x | -9.21% |
| 2024-03-31 | ₹18.85 Billion | ₹5.35 Billion | 0.284x | +5.82% |
| 2023-03-31 | ₹17.00 Billion | ₹4.56 Billion | 0.268x | -7.28% |
| 2022-03-31 | ₹15.44 Billion | ₹4.47 Billion | 0.289x | -7.25% |
| 2021-03-31 | ₹12.76 Billion | ₹3.98 Billion | 0.312x | +15.85% |
| 2020-03-31 | ₹10.54 Billion | ₹2.84 Billion | 0.269x | +17.20% |
| 2019-03-31 | ₹9.51 Billion | ₹2.19 Billion | 0.230x | -7.30% |
| 2018-03-31 | ₹7.95 Billion | ₹1.97 Billion | 0.248x | -4.36% |
| 2017-03-31 | ₹6.62 Billion | ₹1.72 Billion | 0.259x | -10.07% |
| 2016-03-31 | ₹5.10 Billion | ₹1.47 Billion | 0.288x | +1.14% |
| 2015-03-31 | ₹3.43 Billion | ₹978.50 Million | 0.285x | -32.12% |
| 2014-03-31 | ₹2.33 Billion | ₹979.58 Million | 0.420x | -22.03% |
| 2013-03-31 | ₹1.64 Billion | ₹881.31 Million | 0.538x | -7.47% |
| 2012-03-31 | ₹1.17 Billion | ₹681.28 Million | 0.582x | +30.20% |
| 2011-03-31 | ₹934.94 Million | ₹417.87 Million | 0.447x | -- |